@kervio Assuming you are correct (which I don't - no disrepesct but there's many smart commentators coming to different conclusions right now), it's shuddering to think where MSB would be right now if Covid hadn't come along this year. The share price would be shot to bits and the company still years away from significant revenues (and that's assuming efficacy in back pain and heart, which is not guaranteed).
A LOT riding on the ARDS read out. I'm not confident it will be the white knight people are hoping it will be. Could go either way.
MSB to dispute FDA finding in Type A meeting, page-359
-
- There are more pages in this discussion • 659 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.028(2.31%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.758M | 4.039M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 48 | 83858 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 117305 | 17 |
View Market Depth
| Last trade - 15.03pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |